Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique

France

1 October 2019 - 30 September 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique published between 1 October 2019 - 30 September 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
1 0.01

Outputs by subject (Share)

Subject Count Share
Life Sciences 1 0.01

1 October 2019 - 30 September 2020

International vs. domestic collaboration by Share

  • 2.95% Domestic
  • 97.05% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (7 total)

  • Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique, France
  • Domestic institution
  1. Bioinformatics and Computational Systems Biology of Cancer, France (0.01)
    0.01
    0.01
  2. Centre for Research in Epidemiology and Population Health (CESP), France (0.01)
    0.01
    0.01
  3. Curie Institute, France (0.01)
    0.01
    0
  4. Genetics and Biology of Cancers, France (0.01)
    0.01
    0
  5. Institut Mines-Télécom (IMT), France (0.01)
    0.01
    0
  6. University of Paris-Sud (UPSud), France (0.01)
    0.01
    0
  7. University of Versailles Saint-Quentin-en-Yvelines (UVSQ), France (0.01)
    0.01
    0

Top 10 international collaborators by Share (204 total)

  • Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique, France
  • Foreign institution
  1. University of Cambridge, United Kingdom (UK) (0.06)
    0.01
    0.05
  2. National Institutes of Health (NIH), United States of America (USA) (0.06)
    0.01
    0.05
  3. Helmholtz Association of German Research Centres, Germany (0.05)
    0.01
    0.04
  4. Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Italy (0.04)
    0.01
    0.03
  5. Centre for Cancer Genetic Epidemiology (CCGE), University of Cambridge, United Kingdom (UK) (0.04)
    0.01
    0.03
  6. Netherlands Cancer Institute (NKI), Netherlands (0.03)
    0.01
    0.03
  7. Pomeranian Medical University (PMU), Poland (0.03)
    0.01
    0.02
  8. Erasmus University Rotterdam (EUR), Netherlands (0.03)
    0.01
    0.02
  9. Hannover Medical School (MHH), Germany (0.03)
    0.01
    0.02
  10. Comprehensive Cancer Center Erlangen-EMN (CCC), FAU, Germany (0.03)
    0.01
    0.02

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique

Participating institutions

Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER